Cytek BiosciencesCTKB +0.11%71 Days Inventory is 195.85 as of Mar. 2026, which is 8% below its 10-year median of 214.00. GuruFocus rates CTKB with a GF Score™ of 71/100 and a GF Value™ of $5.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Cytek Biosciences ranks worse than 50.51% on this metric.
The historical rank and industry rank for Cytek Biosciences's Days Inventory or its related term are showing as below:
CTKB'
s Days Inventory Range Over the Past 10 Years
Min: 173.64 Med: 214 Max: 238.05
Current: 181.14
During the past 7 years, Cytek Biosciences's highest Days Inventory was 238.05. The lowest was 173.64. And the median was 214.00.
CTKB's Days Inventory is ranked worse than 50.51% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs CTKB: 181.14
Cytek Biosciences's Days Inventory
increased
from Mar. 2025 (191.15) to Mar. 2026 (195.85).
It might indicate that Cytek Biosciences's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cytek Biosciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cytek Biosciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.11.
Cytek Biosciences (NAS:CTKB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cytek Biosciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cytek Biosciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cytek Biosciences Days Inventory Related Terms
Cytek Biosciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Cytek Biosciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CTKB vs BBNX, TCMD, NPCE: Days Inventory Comparison
For the Medical Devices subindustry, Cytek Biosciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cytek Biosciences Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cytek Biosciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cytek Biosciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cytek Biosciences (CTKB) has a Days Inventory of 195.85 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cytek Biosciences and its competitors. This is near median its historical median of 214.00. Over the past decade, Cytek Biosciences' Days Inventory has ranged from 173.64 to 238.05. According to the industry distribution chart, Cytek Biosciences ranks #397 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Cytek Biosciences' Days Inventory too high?
Cytek Biosciences' current Days Inventory of 195.85 is near median its 10-year median of 214.00. Over the past 10 years, this metric has ranged from a low of 173.64 to a high of 238.05. The Medical Devices & Instruments industry median Days Inventory is 179.86. Cytek Biosciences' value of 195.85 is 8.9% above this industry median. Based on the distribution chart, Cytek Biosciences ranks #397 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Cytek Biosciences has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cytek Biosciences' Days Inventory compare to BBNX and TCMD?
According to the Medical Devices & Instruments industry distribution chart, Cytek Biosciences ranks #397 out of 786 companies for Days Inventory. This places Cytek Biosciences in the lower half of its industry. The industry median Days Inventory is 179.86. Cytek Biosciences' value of 195.85 is 8.9% above this benchmark. Historically, Cytek Biosciences' own Days Inventory has ranged from 173.64 to 238.05 over the past decade. While the company's 10-year median is 214.00 vs. the industry median of 179.86, Cytek Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cytek Biosciences's current Days Inventory of 195.85 is 8.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cytek Biosciences and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cytek Biosciences's current Days Inventory is 195.85, which is near median its own 10-year median of 214.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytek Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Cytek Biosciences (CTKB) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.82, compared to a current price of $4.46 — trading 23.4% below its estimated fair value. The current Days Inventory is 195.85, which is near median its 10-year median of 214.00 and 8.9% above the Medical Devices & Instruments industry median of 179.86. Cytek Biosciences' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cytek Biosciences (CTKB), the current Days Inventory is 195.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cytek Biosciences (CTKB) Overvalued in 2026?
Based on GuruFocus' analysis, Cytek Biosciences stock appears to be undervalued.
The current stock price of $4.46 is trading 23.4% below its estimated GF Value™ of $5.82.
GuruFocus considers Cytek Biosciences to be Modestly Undervalued.
Key valuation signals for CTKB:
Days Inventory: 195.85 (near median its 10-year median of 214.00)
GF Value™: $5.82 vs. price of $4.46 (23.4% below fair value)
Industry Position: 8.9% above the Medical Devices & Instruments median (#397 of 786)
No single metric tells the full story. See the CTKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
71GF Score
Get the complete analysis for CTKB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CTKB has been successfully added to your 
